These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5556186)

  • 1. In vitro activity of cephalosporin antibiotics against Gram-positive bacteria.
    Kayser FH
    Postgrad Med J; 1971 Feb; 47():Suppl:14-20. PubMed ID: 5556186
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro comparison of the antibacterial activity of 1st, 2d, and 3d generation cephalosporins].
    Messmer JC; Lecaillon-Thibon E; Bon F; Soler H
    Sem Hop; 1983 Sep; 59(34):2389-92. PubMed ID: 6314522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the antibacterial activity of 3d generation cephalosporin antibiotics in vitro].
    Absolonová V; Wolfová J; Pribyslavská H; Bébrová E; Klazarová H; Klimesová M; Kawaciuková J; Nováková L; Lochmann O
    Cesk Epidemiol Mikrobiol Imunol; 1984 Sep; 33(5):282-90. PubMed ID: 6238680
    [No Abstract]   [Full Text] [Related]  

  • 10. [A review of new cephalosporin antibiotics].
    Hupková M; Blahová J; Babálová M; Krcméry VSr
    Vnitr Lek; 1994 Feb; 40(2):118-21. PubMed ID: 8140760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effectiveness of newly introduced cephalosporin antibiotics in vitro].
    Absolonová V; Potuznik V; Lochmann O; Wolfová J; Klazarová H; Klimesová M
    Cesk Epidemiol Mikrobiol Imunol; 1982 Nov; 31(6):338-44. PubMed ID: 6216962
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimicrobial activity of 7 beta-[N-(arylmethyloxyimino) acetamido]cephalosporanic acid derivatives.
    Macchia M; Menchini E; Orlandini E; Rossello A; Broccali G; Visconti M
    Farmaco; 1995 Oct; 50(10):713-8. PubMed ID: 8590579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the antibiotic activity of cefuroxime].
    Bil'ko IP; Mil'chenko KP; Ginzburg TS; Sokalo SV
    Antibiotiki; 1982 Aug; 27(8):595-8. PubMed ID: 6751214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime: the next generation?
    Sanders CC
    Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of susceptibility and resistance of twenty-five bacterial strains by analysis of MIC database of cephalosporins and oxacephalosporins.
    Kodama Y; Inouye S
    J Antibiot (Tokyo); 1997 Mar; 50(3):246-55. PubMed ID: 9127196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.